Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine

Gary Berman, Robert Croop, David Kudrow, Philip Halverson, Meghan Lovegren, Alexandra C. Thiry, Charles M. Conway, Vladimir Coric, Richard B. Lipton

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine'. Together they form a unique fingerprint.

Medicine & Life Sciences